Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in Diffuse Lewy body disease, Pick’s disease, and Corticobasal Degeneration

  • D. W. Dickson
  • M. B. Feany
  • S.-H. Yen
  • L. A. Mattiace
  • P. Davies
Part of the Journal of Neural Transmission Supplement book series (NEURAL SUPPL, volume 47)

Summary

Increasing use of immunocytochemistry for evaluation of dementia disorders has revealed histopathological alterations that were previously unknown, even with sensitive silver techniques. Disorders [Pick’s disease (PD), diffuse Lewy body disease (DLBD) and corticobasal degeneration (CBD)] in which immunocytochemistry has revealed occult pathology are discussed. All three disorders have neurofilament (NF) immunoreactive neuronal alterations in the neocortex. In DLBD round, eosinophilic cytoplasmic inclusions referred to as cortical Lewy bodies are neurofilament-positive, while in both PD and CBD neurofilament epitopes are expressed in irregularly swollen neurons and their proximal cell processes, which are referred to as ballooned neurons. Interestingly, the cortical neuronal population that is vulnerable to Lewy bodies is similar to that which is vulnerable to ballooned neurons. Furthermore, Lewy bodies can occasionally be detected within the cytoplasm of ballooned neurons. Besides neurofilament-immunoreactivity, Lewy bodies are immunoreactive for ubiquitin, while ballooned neurons are inconsistently stained with antibodies to ubiquitin. Both Lewy bodies and ballooned neurons can be appreciated with routine histology, but they are much easier to detect with immunocytochemistry. In contrast, a new type of neuritic alteration in the hippocampal CA2/3 region has been recognized in DLBD. These dystrophic neurites cannot be appreciated with routine histology and are only optimally seen with immunocytochemistry for ubiquitin. Their presence is a certain indication of the presence of cortical Lewy bodies.

The microtuble associated protein tau is the major constituent of neurofibrillary tangles in Alzheimer’s disease (AD). Biochemical studies have shown that Pick bodies, argyrophilic neuronal inclusions that are highly characteristic of, if not pathognomonic for PD are also composed of abnormal tau protein. Along with Pick bodies, tau has recently been detected in glial cells in PD. Similar so-called “gliofibrillary tangles” are increasingly recognized in progressive supranuclear palsy. Previously, CBD was considered to be free of such lesions, but recent studies have revealed widespread tau-positive neuronal and glial cytoskeletal lesions in CBD. A distinctive type of tau-positive glial lesion in CBD is characterized by annular clusters of grain-like tau immunoreactivity reminiscent of a neuritic plaque in AD, except that the clusters are devoid of amyloid. The tau-positive profiles are consistently located around a central astrocyte cell body. Double labeling studies with glial fibrillary acidic protein, vimentin and CD44, which are markers for reactive astrocytes, demonstrates tau immunoreactivity within astrocytic processes; these “astrocytic plaques” appear to be specific for CBD. Although NF, ubiquitin and tau proteins are present in diverse neuronal and glial inclusions in these disorders, the morphology and distribution of these lesions differentiate non-AD dementias.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abe H, Yagishita S, Amano N, Iwabuchi D, Hasegawa K, Kowa K (1992) Argyrophilic glial intracytoplasmic inclusions in multiple system atrophy immunocytochemical and ultrastructural study. Acta Neuropathol 84: 273–277PubMedCrossRefGoogle Scholar
  2. Ball MJ (1979) Topography of Pick inclusion bodies in hippocampi of demented patients. A quantiative study. J Neuropathol Exp Neurol 38: 614–620PubMedCrossRefGoogle Scholar
  3. Binder LI, Frankfurter A, Rebum LI (1985) The distribution of tau in the mammalian central nervous system. J Cell Biol 101: 1371–1378PubMedCrossRefGoogle Scholar
  4. Braak H, Braak E, Grundke-Iqbal I, Iqbal K (1986) Occurrence of neuropil threads in the senile human brain and in Alzheimer’s disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett 65: 351–355PubMedCrossRefGoogle Scholar
  5. Braak H, Braak E (1987) Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes. Neurosci Lett 76: 124–127PubMedCrossRefGoogle Scholar
  6. Braak H, Braak E, Yilmazer D, de Vos RA, Jansen EN, Bohl J, Jellinger K (1994) Amygdala pathology in Parkinson’s disease. Acta Neuropathol 88: 493–500PubMedCrossRefGoogle Scholar
  7. Clark AW, Manz HJ, White CL 3d, Lehmann J, Miller D, Coyle JT (1986) Cortical degeneration with swollen chromatolytic neurons: its relationship to Pick’s disease. J Neuropathol Exp Neurol 45: 268–284PubMedCrossRefGoogle Scholar
  8. Crystal HA, Dickson DW, Sliwinski M, Lipton R, Grober E, Marks-Nelson H, Antis P (1993) Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol 34: 566–573PubMedCrossRefGoogle Scholar
  9. Davis DG, Wang HZ, Markesbery WR (1992) Image analysis of neuropil threads in Alzheimer’s, Pick’s, diffuse Lewy body disease and in progressive supranuclear palsy. J Neuropathol Exp Neurol 51: 594–600PubMedCrossRefGoogle Scholar
  10. Dickson DW, Wu E, Crystal HA, Mattiace LA, Yen S-HC, Davies P (1992) Alzheimer and age-related pathology in diffuse Lewy body disease. In: Boller F, Forcette F, Khachaturian Z, Poncet M, Christen Y (eds) Heterogeneity of Alzheimer’s disease. Springer, Berlin Heidelberg New York Tokyo, pp 168–186Google Scholar
  11. Dickson DW, Yen S-H (1994) Ubiquitin, the cytoskeleton and neurodegenerative disease. In: Mayer RJ, Brown IR (eds) Heat shock or stress proteins and the nervous system. Academic Press, London, pp 235–264Google Scholar
  12. Dickson DW, Ksiezak-Reding H, Liu W-K, Davies P, Crowe A, Yen S-HC (1992) Immunocytochemistry of neurofibrillary tangles (NFT) with antibodies to subregions of tau protein: identification of hidden and cleaved epitopes and a new phosphorylation site. Acta Neuropathol 84: 596–605PubMedCrossRefGoogle Scholar
  13. Dickson DW, Ruan D, Crystal H, Mark MH, Davies P, Kress Y, Yen S-H (1991) Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer’s disease: light and electron microscopic immunocytochemistry of CA2–3 neurites specific to DLBD. Neurology 41: 1402–1409PubMedGoogle Scholar
  14. Dickson DW, Schmidt ML, Lee VM-Y, Trojanowski JQ, Yen S-H (1994) Hippocampal neurites in diffuse Lewy body disease• immunocytochemical characterization and local origin Acta Neuropathol 87: 269–276PubMedCrossRefGoogle Scholar
  15. Dickson DW, Wertkin A, Kress Y, Ksiezak-Reding H, Yen S-H (1990) Ubiquitin-immunoreactive structures in normal brains: distribution and developmental aspects. Lab Invest 63: 87–99PubMedGoogle Scholar
  16. Dickson DW, Yen S-H, Suzuki KI, Davies P, Garcia JH, Hirano A (1986) Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes. Acta Neuropathol 71: 216–223PubMedCrossRefGoogle Scholar
  17. Feany MB, Dickson DW (1995) Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 146: 1388–1396PubMedGoogle Scholar
  18. Feany MB, Ksiezak-Reding H, Liu W-K, Vincent I, Yen S-HC, Dickson DW (1995) Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy. Acta Neuropathol 90: 37–43PubMedCrossRefGoogle Scholar
  19. Feany MB, Mattiace LA, Dickson DW (1996) Neuropathologic overlap of progressive supranuclear palsy, Pick’s disease, and corticobasal degeneration. J Neuropathol Exp Neurol 55: 53–67PubMedCrossRefGoogle Scholar
  20. Gearing M, Mirra SS, Hedreen JC, Sumi SM, Hansen LA, Heyman A (1995) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD), part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer’s disease. Neurology 45: 461–466PubMedGoogle Scholar
  21. Geddes JF, Hughes AJ, Lees AJ, Daniel SE (1993) Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. Brain 116: 281–302PubMedCrossRefGoogle Scholar
  22. Gibb WRG, Luthert PJ, Marsden CD (1989) Corticobasal degeneration. Brain 112:1171–1192PubMedCrossRefGoogle Scholar
  23. Goedert M, Spillantini MG, Crowther RA (1991) Tau proteins and neurofibrillary degeneration. Brain Pathol 1: 279–286PubMedCrossRefGoogle Scholar
  24. Greenberg SG, Davies P (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci USA 87: 5827–5831PubMedCrossRefGoogle Scholar
  25. Hauw J-J, Daniel SE, Dickson DW, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for SteeleRichardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44: 2015–2019PubMedGoogle Scholar
  26. Horoupian DS, Chu PL (1994) Unusual case of corticobasal degeneration with tau/ Gallyas-positive neuronal and glial tangles. Acta Neuropathol 88: 592–598PubMedCrossRefGoogle Scholar
  27. Ihara Y, Nukina N, Miura R, Ogawara M (1988) Phosphorylated tau protein is integrated in paired helical filaments in Alzheimer disease. J Biochem 99: 1807–1810Google Scholar
  28. Ikeda K, Akiyama H, Haga C, Kondo H, Arima K, Oda T (1994) Argyrophilic thread-like structure in corticobasal degeneration and supranuclear palsy. Neurosci Lett 174: 157–159PubMedCrossRefGoogle Scholar
  29. Iqbal K, Grundke-Iqbal I, Smith AJ, George L, Tung Y-C, Zaidi T (1989) Identification and localization of tau peptide to paired helical filaments of Alzheimer disease. Proc Natl Acad Sci USA 86: 5646–5650PubMedCrossRefGoogle Scholar
  30. Iwatsubo T, Hasegawa M, Ihara Y (1994) Neuronal and glial tau-positive inclusions in diverse neurologic diseases share common phosphorylation characteristics. Acta Neuropathol 88: 129–136PubMedCrossRefGoogle Scholar
  31. Kosaka K, Yoshimura M, Ikeda K, Budka H (1984) Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree — a new disease? Clin Neuropathol 3: 185–192PubMedGoogle Scholar
  32. Kowall NW, Kosik KS (1987) Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer’s disease. Ann Neurol 22: 639–643PubMedCrossRefGoogle Scholar
  33. Ksiezak-Reding H, Morgan K, Mattiace LA, Davies P, Liu W-K, Yen S-H, Weidenheim KM, Dickson DW (1994) Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am J Pathol 145: 1–14Google Scholar
  34. Lee VM-Y, Balin B, Otvos L Jr, Trojanowski JQ (1991) A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 451: 675–678CrossRefGoogle Scholar
  35. Love S, Saitoh T, Quijada S, Cole GM, Terry RD (1988) Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies. J Neuropathol Exp Neurol 47: 393–405PubMedCrossRefGoogle Scholar
  36. Lowe J, Errington DR, Lennox G, Pike I, Spendlove I, Landon M, Mayer RJ (1992) Ballooned neurons in several neurodegenerative diseases and stroke contain alpha B crystallin. Neuropathol Appl Neurobiol 18: 341–350PubMedCrossRefGoogle Scholar
  37. Mochizuki A, Mizusawa H, Ohkoshi N, Yoshizawa K, Komatsuzaki Y, Inoue K, Kanazawa I (1992) Argentophilic intracytoplasmic inclusions in multiple system atrophy. J Neurol 239: 311–316PubMedCrossRefGoogle Scholar
  38. Mori H, Nishimura M, Namba Y, Oda M (1994) Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy. Acta Neuropathol 88: 113–121PubMedCrossRefGoogle Scholar
  39. Murayama S, Arima K, Nakazato Y, Satoh J, Oda M, Inose T (1992) Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. 2. Oligodendroglial cytoplasmic inclusions. Acta Neuropathol 84: 32–38PubMedCrossRefGoogle Scholar
  40. Murayama S, Mori H, Ihara Y, Tomonaga M (1990) Immunocytochemical and ultrastructural studies of Pick’s disease. Ann Neurol 27: 394–405PubMedCrossRefGoogle Scholar
  41. Nishimura M, Namba Y, Ideda K, Oda M (1992) Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranculear palsy. Neurosci Lett 143: 35–38PubMedCrossRefGoogle Scholar
  42. Papp MI, Kohn JE, Lantos PL (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy and Shy-Drager syndrome. J Neurol Sci 94: 79–100PubMedCrossRefGoogle Scholar
  43. Pollanen MS, Dickson DW, Bergeron C (1993). Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52: 183–191PubMedCrossRefGoogle Scholar
  44. Rebeiz JJ, Kolodny EH, Richardson EP (1968) Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18: 20–33PubMedCrossRefGoogle Scholar
  45. Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy: a heterogenous degeneration involving the brain stem, basal ganglia and cerebellum, with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10: 333–339PubMedCrossRefGoogle Scholar
  46. Tabaton M, Mandybur TI, Perry G, Onorato M, Autillo-Gambetti L, Gambetti P (1989) The widespread alteration of neufites in Alzheimer’s disease may be unrelated to amyloid deposition. Ann Neurol 26: 771–778PubMedCrossRefGoogle Scholar
  47. Wakabayashi K, Oyanagi K, Makifuchi T, Ikuta F, Honna A, Honna Y, Horikawa Y, Tokiguchi S (1994) Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol 87: 545–553PubMedCrossRefGoogle Scholar
  48. Yamada T, McGeer PL, McGeer EG (1992) Appearance of paired nucleated, taupositive glia in patients with progressive supranuclear palsy brain tissue. Neurosci Lett 35: 99–102CrossRefGoogle Scholar
  49. Yamazaki M, Nakano I, Imazu O, Kaieda R, Terashi A (1994) Astrocytic straight tubules in the brain of a patient with Pick’s disease. Acta Neuropathol 88: 587–591PubMedCrossRefGoogle Scholar
  50. Yen S-H, Dickson DW, Peterson C, Goldman JE (1986) Cytoskeletal abnormalities in neuropathology. In: Zimmerman HM (ed) Progress in neuropathology, vol 6. Raven Press, New York, pp 63–90Google Scholar
  51. Yen S-H, Liu W-K, Hall FL, Yan S-D, Stern D, Dickson DW (1995) Alzheimer neurofibrillary lesions: molecular nature and potential roles of different components. Neurobiol Aging 16: 381–387PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • D. W. Dickson
    • 1
    • 2
  • M. B. Feany
    • 1
  • S.-H. Yen
    • 1
  • L. A. Mattiace
    • 1
  • P. Davies
    • 1
  1. 1.Departments of Pathology and Neurology, and the Rose F. Kennedy Center for Research in Mental Retardation and Human DevelopmentAlbert Einstein College of MedicineBronxUSA
  2. 2.Department of Pathology (Neuropathology)Albert Einstein College of MedicineBronxUSA

Personalised recommendations